Roderick Peter Hafner
30Patents
9h-index
12Co-inventors
72Inventor score
Filing activity: Aug 3, 2001 → Aug 6, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7022313B2 | Hydrogel particle formulation | Human Necessities | 74 | Expired |
| US8910629B2 | Delivery of gases to the nasal airway | Human Necessities | 61 | Active |
| US8899229B2 | Powder delivery devices | Human Necessities | 60 | Active |
| US8875704B2 | Nasal administration | Human Necessities | 44 | Active |
| US8590530B2 | Nasal delivery devices | Human Necessities | 43 | Active |
| US9108015B2 | Nasal delivery devices | Human Necessities | 38 | Active |
| US9144652B2 | Powder delivery devices | Human Necessities | 36 | Active |
| US9649456B2 | Nasal administration | Human Necessities | 23 | Active |
| US8652485B2 | Peptide for vaccine | Chemistry; Metallurgy | 14 | Active |
| US9180098B2 | Compositions with reduced dimer formation | Human Necessities | 4 | Active |
| US8551493B2 | Peptide with reduced dimer formation | Chemistry; Metallurgy | 3 | Active |
| US8551492B2 | Vaccine peptide combinations against cat allergy | Human Necessities | 3 | Active |
| US10112021B2 | Intranasal administration | Human Necessities | 2 | Active |
| US8753644B2 | Grass peptides for vaccine | Human Necessities | 1 | Active |
| US10478574B2 | Nasal administration | Emerging Cross-Sectional Technologies | 1 | Active |
| US10722667B2 | Nasal administration | Human Necessities | 1 | Active |
| US9168295B2 | Vaccine peptide combinations | Human Necessities | 1 | Active |
| US8491910B2 | Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy | Physics | 1 | Active |
| US12083270B2 | Delivery device and method | Human Necessities | 0 | Active |
| US10765829B2 | Delivery of gases to the nasal airway | Human Necessities | 0 | Active |
| US9340580B2 | Peptide with multiple epitopes | Chemistry; Metallurgy | 0 | Active |
| US9744222B2 | Peptide for vaccine | Chemistry; Metallurgy | 0 | Active |
| US10398859B2 | Nasal delivery devices | Human Necessities | 0 | Active |
| US9850281B2 | Cladosporium peptides | Physics | 0 | Active |
| US11690969B2 | Delivery of gases to the nasal airway | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.